Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 743
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 145
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 142
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
Peter V. Markov, Aris Katzourakis, Nikolaos I. Stilianakis
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 251-252
Open Access | Times Cited: 131
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
Spyros Chalkias, Frank Eder, Brandon Essink, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2388-2397
Open Access | Times Cited: 126
Towards SARS-CoV-2 serotypes?
Etienne Simon‐Lorière, Olivier Schwartz
Nature Reviews Microbiology (2022) Vol. 20, Iss. 4, pp. 187-188
Open Access | Times Cited: 102
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (2023) Vol. 382, Iss. 6666
Open Access | Times Cited: 95
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 81
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
Anna Z. Mykytyn, Miruna E. Rosu, Adinda Kok, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e294-e295
Open Access | Times Cited: 55
Population immunity predicts evolutionary trajectories of SARS-CoV-2
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5151-5164.e13
Open Access | Times Cited: 43
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
Wei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 12, pp. 1745-1758.e7
Open Access | Times Cited: 59
Mapping the antigenic diversification of SARS-CoV-2
Karlijn van der Straten, Denise Guerra, Marit J. van Gils, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 56
Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 50
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 42
When to update COVID-19 vaccine composition
Rebecca Grant, Jilian A. Sacks, Priya Abraham, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 776-780
Open Access | Times Cited: 37
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2334-2346
Open Access | Times Cited: 33
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
David Niklas Springer, Michael Bauer, Iris Medits, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 24
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2022-01-28
Antonia Netzl, Sina Türeli, Eric B. LeGresley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 26
Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster Vaccine
Spyros Chalkias, Frank Eder, Brandon Essink, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 20
Computational design of vaccine immunogens
Karla M. Castro, Andreas Scheck, Shuhao Xiao, et al.
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102821-102821
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top